Posts tagged ‘drug discovery’

How are stem cells advancing compound screening and analysis of drug-like properties? Stem cells are emerging as significant reagents in drug...

Advances in Culturing Stem Cells Stem cells may hold the answer to one of the biggest medical challenges, replacing tissues and organs. Exciting...

This is Part 3 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 2). Patient perspective (patient-centered outcomes...

Targeted based drug discovery has been a mainstay of pharmaceutical pipelines for the last 20 years. Identifying and validating novel drug...

Life science companies are known to be one of the most expensive and difficult to start up. We look for an answer as to why in an excellent article...

This month Drug Discovery News published Dr. Kevin Lustig’s editorial discussing how outsourcing is a viable strategy for advancing oncology...

Scientist announced this morning, the launch of MXIS (Market Exchange for Innovative Services), a virtual outsourcing platform for Pfizer...

This is Part 4 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...

Researchers and pharmaceutical companies believe that stem cells, especially induced pluripotent stem cells (iPSC), hold great promise for drug...

Just last week, we wrote about how drug development costs are keeping obesity drugs off the market. This week, we take a look at Alzheimer’s...